Open access · CC-BY via OpenAlex

Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456

LaTonya J. Hickson, Larissa Prata, Shane A. Bobart, Tamara K. Evans, Nino Giorgadze, Shahrukh K. Hashmi, Sandra M. Herrmann, Michael D. Jensen, Qingyi Jia, Kyra L. Jordan, Todd A. Kellogg, Sundeep Khosla, Daniel M. Koerber, Anthony B. Lagnado, Donna K. Lawson

EBioMedicine · 2020 · ▲ 58 citations

Cellular senescence Senolytics Human

＋ Sign in to save

Abstract

In this article, a re-analysis of the raw data has been conducted, which means that some conclusions presented in the paper have changed. The authors have written a Corrigendum which is appended (Appendix 1). In the interests of transparency, they have included de-identified data from the original article in Appendix 2. Download .docx (.54 MB) Help with docx files Download .xlsx (.01 MB) Help with xlsx files Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease“Hit-and-run” treatment with senolytics, which in the case of D + Q have elimination half-lives <11 h, significantly decreases senescent cell burden in humans. Full-Text PDF Open Access

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.ebiom.2019.12.004
Canonical: link ↗
Fetched: 2026-06-14 MST

Cite this

APA

Hickson, L.J., Prata, L., Bobart, S.A., Evans, T.K., Giorgadze, N., Hashmi, S.K., Herrmann, S.M., Jensen, M.D., Jia, Q., Jordan, K.L., Kellogg, T.A., Khosla, S., Koerber, D.M., Lagnado, A.B., Lawson, D.K., LeBrasseur, N.K., Lerman, L.O., McDonald, K.M., McKenzie, T.J., & Passos, J.F. (2020). Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456. <em>EBioMedicine</em>. https://doi.org/10.1016/j.ebiom.2019.12.004

Vancouver

Hickson LJ, Prata L, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, et al. Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456. EBioMedicine. 2020. doi:10.1016/j.ebiom.2019.12.004.

BibTeX

@article{latonya2020Corrig, title = {Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456}, author = {LaTonya J. Hickson and Larissa Prata and Shane A. Bobart and Tamara K. Evans and Nino Giorgadze and Shahrukh K. Hashmi and Sandra M. Herrmann and Michael D. Jensen and Qingyi Jia and Kyra L. Jordan and Todd A. Kellogg and Sundeep Khosla and Daniel M. Koerber and Anthony B. Lagnado and Donna K. Lawson and Nathan K. LeBrasseur and Lilach O. Lerman and Kathleen M. McDonald and Travis J. McKenzie and João F. Passos and Robert J. Pignolo and Tamar Pirtskhalava and Ishran M. Saadiq and Kalli K. Schaefer and Stephen C. Textor}, journal = {EBioMedicine}, year = {2020}, doi = {10.1016/j.ebiom.2019.12.004}, }